atopic dermatitis

Appreciating the role of microbial communities on the skinMicrobial colonization in the development of inflammatory conditions and immune-mediated conditions is a hot research topic, and new dermatologic therapies can potentially result from greater understanding of the role of microbial communities on the skin and in the gut.
Survey puts spotlight on a big problem for children with eczema: BullyingMany children with eczema suffer from bullying because of the skin condition. A new survey reflects what children and caregivers are experiencing, beyond the itch.
Common pediatric disorders in skin of colorPediatric atopic dermatitis and acne have some similarities when these present in skin of color and lighter-skin children. But there are important differences when these common skin conditions affect darker skin types. An expert discusses how treatments should be approached.
Restoring the balance: skin microbiome in atopic dermatitisResearch has demonstrated that staph aureus is in increased supply on the skin of atopic dermatitis patients coupled with less overall diversity in the number of bacteria on their skin, suggesting therapies that achieve balance in the skin microbiome could help to manage atopic dermatitis.
Pattern distinguishes atopic, contact dermatitisPart of the management of contact dermatitis is identifying the offending agent through patch testing and eliminating contact with the offending agent.
Can stress cause skin disease?Science is finally catching up to common sense when it comes to the idea that stress worsens skin conditions.
Investigative eczema drug shows positive phase 2 resultsUK-based Ziarco Pharma Ltd. recently announced positive phase 2a results for ZPL-389, a once daily oral histamine H4 receptor antagonist, for the treatment of moderate to severe atopic dermatitis.
Dupilumab demonstrates promising resultsThe systemic therapy dupilumab met primary endpoints in two phase 3 studies on adults with in inadequately controlled moderate-to-severe atopic dermatitis.
Merger to boost eczema offeringsPfizer and Anacor Pharmaceuticals announced in May that the pharmaceutical companies merged with Pfizer acquiring Anacor for about $5.2 billion. Dermatologists say merger is a good move for patients.
Hard water in home linked to eczema in infancy
Hard water in home linked to eczema in infancyThis is an interesting and credible study of infants, suggesting there probably is a link, one expert notes. It remains to be seen whether water softeners and chlorine filters should be recommended one day. Read more on the data.